Company Filing History:
3 out of 8 
3 out of 288 
3 out of 505 
Years Active: 2021-2023
Title: Emily Marshall: A Pioneer in HIV Vaccine Development
Introduction
Emily Marshall, located in Portland, OR, is an innovative inventor known for her impactful contributions to the field of medicine, particularly in the development of HIV vaccines. With a total of three patents to her name, she is at the forefront of research aimed at combating HIV through advanced vaccine strategies.
Latest Patents
Emily's latest patents focus on groundbreaking HIV-1 vaccines utilizing population episensus antigens determined through the EpiGraph approach. These patents detail the design and production of a vaccine that aims to optimally cover the diversity of HIV strains within specific geographic areas. The methods outlined include vaccine antigen design, the induction of an effector memory T cell response, and effective strategies for treating HIV-1 in subjects in need of intervention.
Career Highlights
Throughout her career, Emily has made significant strides at prominent organizations including Vir Biotechnology, Inc. and Triad National Security, LLC. Her work at these companies has facilitated advancements in personalized medicine and vaccine development, reiterating her status as a remarkable inventor in her field.
Collaborations
In her journey, Emily has collaborated with talented professionals such as Eric Bruening and Klaus Frueh. These partnerships have enhanced her research and contributed to the success of her inventive work, leading to effective solutions for HIV treatment.
Conclusion
Emily Marshall exemplifies dedication to innovation and impact through her patents and collaborations in HIV vaccine research. Her pioneering work continues to inspire progress in the medical field, showcasing the importance of tailored vaccine strategies in public health.